News
CSL Behring AG publishes Offer Prospectus on public tender offer for all publicly held shares of Vifor Pharma Ltd.
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220117005418/en/
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
CSL
Rekord-Umsatzwachstum im Jahr 2021
Record sales growth in 2021
QXC Communications Launches Advanced Streaming Service to Meet Consumer Demand and Increase Subscriber Base
Swiss Re Insurance-Linked Investment Management Ltd enters a strategic partnership with Swedish pension fund Alecta
Swiss Re Insurance-Linked Investment Management AG geht strategische Partnerschaft mit schwedischer Pensionskasse Alecta ein
Holcim to acquire PRB Group expanding Solutions & Products
Holcim wird PRB Group übernehmen und baut Lösungen & Produkte aus
Holcim and Magment develop concrete solutions to recharge electric vehicles
EQS-News: Holcim completes acquisition in the US Pacific Northwest region
EQS-News: Julius Bär Gruppe verkauft Wergen & Partner Vermögensverwaltungs AG im Rahmen eines Management-Buyouts
EQS-News: Julius Baer Group to sell Wergen & Partner Wealth Management Ltd in a management buyout
EQS-News: Julius Bär meldet Abschluss des Aktienrückkaufprogramms 2021
EQS-News: Julius Baer announces completion of 2021 share buy-back programme
EQS-Adhoc: The Kudelski Group Enters into a Sale and Leaseback Transaction for its Cheseaux Properties
EQS-Adhoc: Holcim to acquire Malarkey Roofing Products
EQS-Adhoc: Holcim übernimmt Malarkey Roofing Products
EQS-Adhoc: Veränderung im Verwaltungsrat
EQS-Adhoc: Changes to Board of Directors
EQS-Adhoc: Evie Kostakis to succeed Dieter Enkelmann as CFO of Julius Baer
EQS-Adhoc: Evie Kostakis folgt auf Dieter Enkelmann als CFO von Julius Bär
EQS-News: Valora now to rely on vending machines as well - roll-out of 300 k kiosk machines across Switzerland by the end of 2022
EQS-News: Valora setzt neu auch auf Verkaufsautomaten - Rollout von schweizweit 300 k kiosk Automaten bis Ende 2022
Vifor Pharma reports positive outcome of the phase-IIIb DIAMOND trial of Veltassa®
Regulatory News:
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Vifor Pharma today announced positive findings in the completed phase-IIIb DIAMOND trial of Veltassa® in heart failure patients with
Vifor Pharma and American Regent announce settlement of Injectafer® patent litigation
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211219005059/en/
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Vifor